Director at DaVita (NYSE: DVA) receives 250-share stock award

Rhea-AI Filing Summary

Arway Pamela M reported acquisition or exercise transactions in this Form 4 filing.

DaVita Inc. director Pamela M. Arway reported receiving a grant of 250 shares of DaVita common stock on May 15, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related stock award rather than an open-market purchase.

Following this grant, Arway directly holds 26,945 shares of DaVita common stock. This filing reflects a small, routine equity award that modestly increases her direct ownership stake in the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Arway Pamela M

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	250	$0.00	--

Holdings After Transaction: Common Stock — 26,945 shares (Direct, null)

Footnotes (1)

Key Figures

Stock award size: 250 shares Award price: $0.00 per share Post-transaction holdings: 26,945 shares

3 metrics

Stock award size 250 shares Grant of DaVita common stock on May 15, 2026

Award price $0.00 per share Stated price for the 250-share grant

Post-transaction holdings 26,945 shares Total DaVita common shares held directly after grant

Key Terms

Common Stock, Grant, award, or other acquisition, Form 4, transaction code "A"

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

transaction code "A" financial

"transaction_code: "A""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Arway Pamela M

(Last) (First) (Middle)

C/O DAVITA INC.

2000 16TH STREET

(Street)

DENVER COLORADO 80202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		250	A	$0	26,945	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stephanie N. Berberich, Attorney-in-Fact	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did DaVita (DVA) director Pamela M. Arway report in this Form 4?

Pamela M. Arway reported receiving a grant of 250 shares of DaVita common stock. The award was recorded at a price of $0.00 per share, indicating a compensation-related stock grant rather than an open-market purchase.

How many DaVita (DVA) shares does Pamela M. Arway hold after this transaction?

After the 250-share grant, Pamela M. Arway directly holds 26,945 DaVita common shares. This total reflects her position following the reported award on May 15, 2026, as disclosed in the Form 4 filing.

Was the DaVita (DVA) insider transaction a stock purchase or a grant?

The transaction was a grant or award of 250 DaVita common shares to director Pamela M. Arway. It is coded as a grant, award, or other acquisition, not as an open-market stock purchase or sale.

What transaction code is used for Pamela M. Arway’s DaVita (DVA) stock award?

The filing uses transaction code “A,” described as a grant, award, or other acquisition. This code confirms the 250 DaVita common shares were received as an equity award rather than bought in the open market.

Does this DaVita (DVA) Form 4 show any insider stock sales?

No insider stock sales are shown in this Form 4. It reports only a grant of 250 DaVita common shares to director Pamela M. Arway, increasing her direct holdings to 26,945 shares after the transaction.